Pyrrol-2-one Compounds for Bacterial Skin Lesion Treatment

The European Patent Office published patent application EP3487495A1, granted to Unilever IP Holdings B.V. and Unilever Global IP Limited, covering 4-(4-chlorophenyl)-5-methylene-pyrrol-2-one and 5-methylene-4-(p-tolyl)pyrrol-2-one compounds for treating bacterial skin lesions. The patent is designated across 31 European states including all EU member states, with no immediate compliance obligations for third parties.

Pyrrol-2-one therapeutic compound for bacterial respiratory infection

The European Patent Office published patent application EP3487494A1 for Unilever IP Holdings B.V. and Unilever Global IP Limited, covering 4-(4-chlorophenyl)-5-methylene-pyrrol-2-one and 5-methylene-4-(p-tolyl)pyrrol-2-one compounds for treating bacterial respiratory tract infections. The patent application was filed with claims under IPC classifications A61K 31/4015 and A61P 31/00.

Takeda patent for treating immune-related gastrointestinal adverse events

Takeda patent for treating immune-related gastrointestinal adverse events

Myoelectric Prosthesis Setup Method Patent

The European Patent Office published patent EP3790515A1 for Otto Bock Healthcare Products GmbH covering methods and systems for setting up myoelectric-controlled prosthesis systems. The patent application includes six inventors and is classified under IPC codes A61F 2/72, A61N 1/04, and A61B 5/389. The publication designates all EU member states and is effective March 25, 2026.

Femur Plate Patent for Fracture Fixation

The European Patent Office granted Stryker European Operations Holdings LLC patent EP3782567A1 for a femur plate system designed for fracture fixation. The patent, filed by five named inventors, covers devices classified under A61B 17/80 (osteosynthesis plates) and is valid across 38 designated European contracting states including all major EU economies.

Transversely Expandable Minimally Invasive Intervertebral Cage Patent

The European Patent Office published patent application EP3934574A1 for Octagon Spine Inc.'s transversely expandable minimally invasive intervertebral cage and insertion/extraction device. The invention, filed by inventors JIMENEZ, Omar F. and SAFRIS, Yefim I., covers spinal cage technology classified under IPC A61F 2/44. The patent is designated for all European extension states including DE, FR, GB, IT, ES, and 28 other jurisdictions.

Stent Graft with Fenestration

The European Patent Office published patent application EP3881800A1 for a stent graft with fenestration, filed by RIBS, Inc. (inventor: OHKI Takao). The patent application was published March 25, 2026, designating all EU member states. This represents a routine patent publication with no immediate compliance implications for regulated entities.

Micro-Devices for Treatment of an Eye

European Patent Office published patent application EP3761928A1 for Avedro, Inc., covering micro-devices for treatment of an eye. The patent application lists five inventors and designates all EU/EEA member states. This publication grants Avedro exclusive rights to the claimed eye treatment technology in Europe.

Daily Federal Register Issue Index

The Office of the Federal Register published its daily index for April 1, 2026, cataloging 92 documents across 36 federal agencies. The issue contains 79 notices, 4 proposed rules, 9 final rules, and 3 significant documents spanning 388 pages.

Nasdaq Texas extends GPS antenna service removal deadline

The SEC published Nasdaq Texas LLC's filing to extend the designated removal date for dedicated GPS antenna service at its Carteret, NJ co-location facility (NY 11). The Exchange's Rule General 8, Section 1(d) governs this co-location service, which provides time synchronization to GPS network time for customers' transactional timestamping needs. This is the second extension of the removal deadline for existing GPS antenna customers.